The efficacy and safety of TRT in men with treated and untreated prostate cancer

As we have mentioned frequently before, the use of testosterone replacement therapy (TRT) in men diagnosed with and/or treated for prostate cancer has been highly controversial, and the data supporting a role for TRT in such patients has been limited. … READ MORE …

Is it possible that testosterone supplements could actually reduce risk for prostate cancer?

According to a report on the MedPage Today web site, three presentations given at the recently completed annual meeting of the American Urological Association addressed prostate cancer risk among men taking testosterone supplements. … READ MORE …

The use of TRT in hypogonadal prostate cancer patients

We may be seeing the beginning of a real turning point in opinions about the role of testosterone replacement therapy (TRT) in men who have been treated for prostate cancer. … READ MORE …

Testosterone replacement therapy after radiation therapy

Many urologists these days are fairly comfortable prescribing testosterone replacement therapy (TRT) for men who have had a radical prostatectomy and whose PSA has stayed at undetectable levels for some time. However, … READ MORE …

TRT and prostate cancer risk in hypogonadal men

A new paper in the Journal of Urology provides data from European males with clinically low levels of serum testosterone indicating that, in these patients, testosterone replacement therapy (TRT) was not associated with any increase in risk for a diagnosis of prostate cancer. … READ MORE …

TRT after radical prostatectomy for localized prostate cancer in hypogonadal males

A new paper just published in the Journal of Urology addresses (again) the controversial issue of whether the use of testosterone replacement therapy (TRT) is appropriate as a management strategy after first-line treatment for hypogonadal patients. … READ MORE …

Weekend prostate cancer news update: Saturday, July 26

Articles summarized in this weekend news update include information about:

  • The value of endorectal MRI imaging in staging patients with respect to whether they have cancer confined to the prostate or extracapsular disease
  • Patterns of disease recurrence after salvage radical prostatectomy for patients with radiation-recurrent disease
  • The potential of PSA kinetics to improve prediction of likelihood for survival in men with hormone-refractory prostate cancer, and
  • The appropriateness of testosterone replacement therapy in men with hypogonadism after curative treatment for prostate cancer … MORE …